Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
288
-
Total 13F shares, excl. options
-
50M
-
Shares change
-
-144K
-
Total reported value, excl. options
-
$5.55B
-
Value change
-
-$22.3M
-
Put/Call ratio
-
0.55
-
Number of buys
-
148
-
Number of sells
-
-138
-
Price
-
$111.01
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q1 2021
334 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q1 2021.
HAEMONETICS CORP - Common Stock (HAE) has 288 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50M shares
.
Largest 10 shareholders include Capital Research Global Investors (6.22M shares), VANGUARD GROUP INC (4.88M shares), BlackRock Inc. (4.8M shares), Neuberger Berman Group LLC (2.83M shares), FMR LLC (2.25M shares), FRANKLIN RESOURCES INC (1.86M shares), WELLINGTON MANAGEMENT GROUP LLP (1.43M shares), Capital World Investors (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (1.28M shares), and STATE STREET CORP (1.23M shares).
This table shows the top 288 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.